Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1999; 81(05): 852
DOI: 10.1055/s-0037-1614585
DOI: 10.1055/s-0037-1614585
Letters to the Editor
Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?
Further Information
Publication History
Received
31 December 1998
Accepted
08 February 1999
Publication Date:
09 December 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199905/lookinside/thumbnails/10.1055s-0037-1614585-1.jpg)
-
References
- 1 Baglin T, Beacham E.. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? Thromb Haemost. 1998; 80:: 1036-7.
- 2 Yee TT, Lee CA, Riddel A, Pasi KJ. From Tolerance to Intolerance of factor VIII: A Clinical Case Presentation. C.M.E.. Bulletin 1997; 1: 16-7.
- 3 Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in haemophilia A. Advances in experimental medicine and biology.. Ed by Aledort L. M., Hoyer L. W., Lusher J. M., Reisner H. M., and C. G.. White II. 1996; 386: 19-34.
- 4 Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia.. Br J Haematol 1997; 96: 425